Aberrant activation of TRIP13-EZH2 signaling axis promotes

€ 20.50

4.7
(746)
Auf Lager
Beschreibung

Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma

Regulation of apoptosis, autophagy and ferroptosis by non‑coding RNAs in metastatic non‑small cell lung cancer (Review)

Targeted therapy of multiple myeloma

IJMS, Free Full-Text

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching

HMGA1-TRIP13 axis promotes invasion, stemness and EMT in a positive

Latest Articles - 科学研究子站

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching

The EZH2-H3K27me3 axis modulates aberrant transcription and apoptosis in cyclophosphamide-induced ovarian granulosa cell injury

Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer - ScienceDirect

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching